| |
|
|
|
Forward Pharma A/S  
|
|
1.28 -0.05 (-0.04%) |
11-21 10:49 |
|
Open: |
1.32 |
Pre close: |
1.33 |
Target:
|
2.17
|
|
High: |
1.37 |
Low: |
1.25 |
Resistance:
|
1.85
2.35
|
|
Volume: |
6,825 |
Market Cap: |
61M |
Support:
|
1.05
0.87
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.31
 |
MACD |
MACD(12,26):
|
-0.19  |
|
MA(20): |
1.40 |
Signal(12,26,9): |
-0.21 |
|
MA(100): |
2.41 |
Stochastic Oscillator |
%K(14,3):
|
19.46 |
|
MA(250): |
2.83 |
%D(3): |
19.97 |
|
Average Volume(K) |
3-Month: |
2835
|
52-Week |
High:
|
5.75 |
|
10-Days: |
3681 |
Low: |
1.05 |
|
RSI |
RSI(14):
|
37.28 |
Change(%): |
-71.6 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-4.7 |
Shares Out. (M) |
47.54 |
|
EPS Est. Current Year |
2.490 |
Return on Assets (ttm) |
-3.8 |
Shares Float (M) |
47.54 |
|
EPS Est. Next Year |
-0.090 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.830 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
29.10 |
|
Forward EPS |
1.#IO |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
0.780 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.63 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-281.22 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-269.23 |
P/CF |
-0.21 |
|
|
|
|
|
|
